Market revenue in 2024 | USD 940.7 million |
Market revenue in 2030 | USD 1,454.4 million |
Growth rate | 7.5% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 39.18% in 2024. Horizon Databook has segmented the Japan cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has a relatively high healthcare expenditure per capita. According to the OECD, in 2023, Japan has spent USD 5251 per capita on health. As the government and private sector continue to invest in healthcare infrastructure and technology, there is greater accessibility to advanced medical treatments, including CRM procedures & devices.
Japan has one of the most rapidly aging populations globally. In September 2022, Japan’s population declined by 820,000, while the number of seniors aged 65 years and older increased by 60,000, reaching a record total of 36.27 million individuals.
This surge in the senior population marked a 0.03% increase from 2021, representing the highest growth rate recorded thus far. As people age, they become more susceptible to cardiac arrhythmias and other heart-related conditions.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into Japan cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account